Search

Your search keyword '"Greib C."' showing total 205 results

Search Constraints

Start Over You searched for: Author "Greib C." Remove constraint Author: "Greib C."
205 results on '"Greib C."'

Search Results

1. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

2. Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases.

3. M. Xenopi Pulmonary Infection: A Randomized Clinical Trial Comparing Rifampin + Ethambutol + Either Clarithromycin or Moxifloxacin: The Camomy Study

4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

5. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

9. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

11. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

12. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

15. Gender differences in the use of cardiovascular interventions in HIV?positive persons; the D:A:D Study

16. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

17. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

22. Évaluation de l’efficacité de deux schémas thérapeutiques (incluant Clarithromycine versus Moxifloxacine) sur la négativation des cultures à 6 mois au cours des infections pulmonaires à Mycobacterium xenopi. L’essai CaMoMy

23. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

24. Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016

30. Management of infective endocarditis and multidisciplinary approach

34. Supplementary Material for: Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management

35. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

38. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

40. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

42. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

43. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

44. Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997‐2008

45. TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

46. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

47. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

Catalog

Books, media, physical & digital resources